Keith Mc Clary
About Keith Mc Clary
Keith Mc Clary is a Manager II, Manufacturing at Bristol Myers Squibb in the Greater Seattle Area. He has extensive experience in manufacturing engineering, having worked at NanoString Technologies, Inc. and MESO SCALE DIAGNOSTICS, LLC., and holds a Bachelor's Degree in Biomedical Engineering from Rutgers University.
Current Role at Bristol Myers Squibb
Keith Mc Clary is currently the Manager II, Manufacturing at Bristol Myers Squibb, located in the Greater Seattle Area. In this role, he develops and validates automation protocols for cell therapy manufacturing processes in ISO 5 environments. His position involves optimizing manufacturing processes for compliance with Good Manufacturing Practice (GMP) standards, ensuring high efficiency and quality in production.
Previous Experience at NanoString Technologies
From 2018 to 2022, Keith Mc Clary served as Manager, Manufacturing Engineering at NanoString Technologies, Inc. in Seattle, Washington. During his tenure, he led the implementation of GMP process improvements, resulting in a significant 15% increase in production efficiency. His remarkable contributions to manufacturing process innovation earned him a company-wide award. Additionally, Keith played a mentorship role, guiding junior engineers and technicians in GMP process development and validation.
Career at MESO SCALE DIAGNOSTICS
Keith Mc Clary's career at MESO SCALE DIAGNOSTICS, LLC. spanned from 2010 to 2018. He held various positions, including Manufacturing Technician, Process Engineer, and Manufacturing Engineering Manager. Notably, he played a critical role in the successful scale-up of a novel diagnostic assay. Furthermore, Keith mentored junior engineers and technicians in GMP process development, and authored a white paper on the integration of automation in GMP manufacturing processes, published in a leading biotechnology journal.
Educational Background
Keith Mc Clary graduated from Rutgers, The State University of New Jersey-New Brunswick with a Bachelor's Degree in Biomedical Engineering, completing his studies from 2005 to 2009. His academic background laid the foundation for his career in manufacturing engineering and process optimization in the biotechnology and pharmaceutical industries.
Industry Contributions and Presentations
Keith Mc Clary has actively contributed to the biotechnology and pharmaceutical industries through various initiatives and presentations. He presented at the 2021 International Society for Cell & Gene Therapy (ISCT) conference, where he discussed advancements in cell therapy manufacturing. His work in developing and validating automation protocols for GMP processes and his mentorship activities have had a lasting impact on the industry.